Vozmozhnye mekhanizmyantiateroskleroticheskogo effektaGlyukofazha (Metformina)

par Lyudmila Viktorovna Nedosugova
Publié 2006

Sistema osteoprotegerin (OPG) -ligand retseptora-aktivatora yadernogo faktora kappa-V (RANKL) pri diabeticheskoy neyroosteoartropatii i obliteriruyushchem ateroskleroze arteriy niz...

par Марианна Viktorovna Yaroslavtseva, Irina Nikolaevna Ul'yanova, Gagik Radikovich Galstyan
Publié 2007

Immunovospalitel'nye markery ateroskleroza u patsientov s narushennoy tolerantnost'yu k glyukoze i sakharnym diabetom 2 tipa

par Lyudmila Alexandrovna Chugunova, N A Galitsina, Olga Yur'evna Sukhareva, Anna Petrovna Knyazeva, Marina Vladimirovna Shestakova
Publié 2005

Soderzhanie nekotorykh pro-i protivovospalitel'nykh tsitokinovu bol'nykh sakharnym diabetom 2 tipas obliteriruyushchim aterosklerozomsosudov nizhnikh konechnostey

par V G Chobit'ko, T I Rodionova, N B Zakharova
Publié 2006

Ateroskleroz i faktory rosta (TGFbl i bFGF) u patsientovs sakharnym diabetom tipa 2

par A N Podgrebel'nyy, Olga Mikhailovna Smirnova, Ivan Ivanovich Dedov, A V Il'in, L V Nikankina, M V Kotel'nikov, Yu I Chernyad'eva, Yury Ivanovich Suntsov
Publié 2005

Medikamentoznaya terapiya ishemii nizhnikh konechnostey u bol'nykh sakharnym diabetom 2 tipa

par Alla Yur'evna Tokmakova, Mikhail Borisovich Antsiferov, Ivan Ivanovich Dedov
Publié 1999